NVCT - Financial Reports List - Nuvectis Pharma, Inc. - IntrinsicAlpha

Nuvectis Pharma, Inc. NVCT

Healthcare - Biotechnology - NASDAQ - US

$ 8.645

-5.92 %

$ 202 M

Market Cap

-7.51

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	100.00%	5.65%	6.07%
Annual Report	FY	10-K	2024-12-31	0.00%	14.65%	100.00%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	29.38%	29.21%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	22.42%	19.56%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-4.35%	-7.19%
Quarterly Report	Q4	8-K	2023-12-31	-2752.35%	-1.38%	-1.30%
Annual Report	FY	10-K	2023-12-31	0.00%	-18.49%	-19.04%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-0.07%	-3.70%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-60.29%	-61.54%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-36.00%	-39.44%

1